Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
55.83
-1.24 (-2.17%)
At close: Sep 17, 2025, 4:00 PM EDT
55.83
0.00 (0.00%)
After-hours: Sep 17, 2025, 7:00 PM EDT
Claritev Market Cap
Claritev has a market cap or net worth of $919.79 million as of September 17, 2025. Its market cap has increased by 506.14% in one year.
Market Cap
919.79M
Enterprise Value
5.52B
1-Year Change
506.14%
Ranking
Category
Stock Price
$55.83
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $919.79M, an increase of 278.51%. That is a compound annual growth rate of 27.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 919.79M | 284.83% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |